Showing results (161-170 of 204) with videos related to
Sort By:
Pageof 21
Oxford Medical Case Reports|June 15, 2019
Management of a pregnant woman with hypouricemia: a case reportKeiichi Kumasawa, Toshio Nakayama, Ayako Hashimoto, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 15, 2010
Presenteeism in college students: reliability and validity of the Presenteeism Scale for StudentsMasateru Matsushita, Hiroyoshi Adachi, Mikako Arakida, et al.Journal of Atherosclerosis and Thrombosis|October 27, 2011
α1-Antitrypsin low-density-lipoprotein serves as a marker of smoking-specific oxidative stressHiromichi Wada, Shuichi Ura, Noriko Satoh-Asahara, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2016
[A Case of Squamous Cell Carcinoma of the Breast]Risa Terasawa, Mitsuhiko Iwamoto, Satoru Tanaka, et al.Cancer Chemotherapy and Pharmacology|March 30, 2018
A phase II, multicenter, single-arm trial of eribulin as first- or second-line chemotherapy for HER2-negative advanced or metastatic breast cancer: evaluation of efficacy, safety, and patient-reported outcomesKosei Kimura, Mitsuhiko Iwamoto, Satoru Tanaka, et al.Anticancer Research|December 7, 2016
A Phase II Study of Adjuvant Chemotherapy of Tegafur-Uracil for Patients with Breast Cancer with HER2-negative Pathologic Residual Invasive Disease After Neoadjuvant ChemotherapySatoru Tanaka, Mitsuhiko Iwamoto, Kosei Kimura, et al.Journal of Surgical Oncology|September 9, 2015
A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breastTakafumi Kondo, Naoki Hayashi, Sachiko Ohde, et al.Clinical Breast Cancer|October 2, 2019
Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast CancerYuko Takahashi, Takayuki Iwamoto, Yoko Suzuki, et al.Journal of Atherosclerosis and Thrombosis|May 14, 2013
Lectin-like oxidized low-density lipoprotein receptor-1 plays an important role in vascular inflammation in current smokersRieko Takanabe-Mori, Koh Ono, Hiromichi Wada, et al.International Journal of Molecular Sciences|September 28, 2023
The TGF-β/UCHL5/Smad2 Axis Contributes to the Pathogenesis of Placenta AccretaKei Hashimoto, Yuko Miyagawa, Saya Watanabe, et al.Pageof 21